SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Samrat Pharmachem

Samrat Pharmachem

BSE: 530125 | NSE: | ISIN: INE103E01016 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Feb 23, 14:34
69.30
0.00 (0.00%)
VOLUME 1,783
AVERAGE VOLUME
5-Day 48,050
10-Day 25,454
30-Day 10,047
VOLUME SHOCKER
5-Day 48,050
10-Day 25,454
30-Day 10,047
Prev. Close
69.30
Open Price
69.30
Bid PRICE (QTY.)
69.30 (24,636)
Offer PRICE (Qty.)
0.00 (0)
VWAP 69.30
Market
Depth

Market Depth (23 Feb 2017)

BUY SELL
QTY PRICE PRICE QTY
25936 69.30 0.00 0
2 69.00 0.00 0
2 68.00 0.00 0
3 67.00 0.00 0
4 66.00 0.00 0
25.97 K Total - Total

Buy Qty

25.97 K

Sell QTY

-

Today's Low/High 69.30 69.30
52 Wk Low/High 22.60 69.30
L/U Price Band 6,240.00 6,930.00

Samrat Pharma is not listed on NSE

Samrat Pharma
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying Samrat Pharma. What's your call on Samrat Pharma today?
Read 3 investor views

Standalone
MARKET CAP (Rs Cr)
21.41
P/E
14.35
BOOK VALUE (Rs)
44.52
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
27.68
EPS (TTM)
4.83
P/C
11.07
PRICE/BOOK
1.56
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
100 new
DELIVERY AVERAGES
3-Day 97.68%
5-Day 81.99%
8-Day 82.07%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Samrat Pharma on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 14-Feb-2017 (Quarterly Results)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

21 February 2017

buy

RAIN Feb Fut

Entry Price (Rs)

79.50

Exit Price (Rs)

83.50

Gain (Rs)

4.00

buy

TechMahindra Feb Fut

Entry Price (Rs)

509.50

Exit Price (Rs)

513.60

Gain (Rs)

4.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 28.55 69.30  
High Price 28.55 69.30  
Low Price 28.50 69.30  
Last Price 28.50 69.30 143.16
Volume 99 1,783 1,701.01
Simple Moving Averages
Days BSE NSE
30 47.30
50 45.00
150 40.11
200 37.18

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Samrat Pharma

News/Videos & Announcements
Stock Advice & Research Reports
Stock Advice
No Advice
Research Reports
No Reports
News Across the Web
Financials
Income Statement
 Standalone Dec'16 Sep'16 Jun'16
Mar'16
Net Sales 18.11 18.65 21.27 19.97
Other Income 0.01 -0.01 0.05 0.02
PBDIT 1.21 0.92 0.62 0.42
Net Profit 0.65 0.42 0.25 0.18
Balance Sheet
Mar'16
(In Rs Cr)
Total Share Capital 3.09
Net Worth 13.76
Total Debt 5.24
Net Block 7.28
Investments 2.00
Total Assets 19.00
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 677.80 1.10 898.00 572.40 162,622.53
Lupin 1454.50 -0.01 1874.30 1294.05 65,670.00
Dr Reddys Labs 2907.90 0.30 3689.00 2803.50 48,193.42
Cipla 592.20 0.74 621.90 458.25 47,640.82
Cadila Health 428.05 -1.50 460.00 320.05 43,821.30
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 16Jun' 16Mar' 16Dec' 15
Promoter47.4947.1947.3047.46
Public (FII + DII)52.5152.8152.7052.54
Others0.000.000.000.00
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
Plot No A2/3445, GIDC, Phase IV,,
City
Ankleshwar
State
Gujarat
Pin Code
393002
Tel. No.
02646-220774 02646-251291
Fax No.
02646-251291
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25960320
Fax No.
022-25960329
MANAGEMENT
Name
Designation
Lalit Mehta
Chairman & M.D & CEO
Rajesh Mehta
Executive Director & CFO
Megh Mehta
Executive Director
Mahendra Pipalia
Director
Samir Kothary
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Vindhya Telelink Recommended on Jan 11th 2017

Recommended price 595.00  |  Peak from reco 735.00 23.58%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Samrat Pharma

Samrat Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 21.41 crore.

The company management includes Lalit Mehta - Chairman & M.D & CEO, Rajesh Mehta - Executive Director & CFO, Megh Mehta - Executive Director, Mahendra Pipalia - Director, Samir Kothary - Director, Renu Dharod - Director.

It is listed on the BSE with a BSE Code of 530125.

Its Registered office is at Plot No A2/3445, GIDC, Phase IV,, Ankleshwar,Gujarat - 393002.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Samrat Pharma